Immerse yourself in the latest technologies at the ADCES Diabetes Tech Conf, Dec 13-14 in Chicago.

Skip to content
Menu
search button
mobile search close icon
Close

Showcasing ADCES in the News

Discover the latest announcements, activities and involvement in diabetes care and education featured in our news releases.

Press Releases

Get a Closer Look at ADCES in the News

As an association that supports the delivery of diabetes care and education, we're actively involved in finding ways to enhance the lives of people living with diabetes, prediabetes and related cardiometabolic conditions.

That means working together with national, state and local communities to support healthcare workers who care for people with diabetes. Find out more about who we are and what we’re doing in our latest news releases.

 

 

ADCES Names Wendy Mobley-Bukstein 2025 Diabetes Care and Education Specialist of the Year

Aug 12, 2024, 11:13 by Danielle McNary
The Association of Diabetes Care & Education Specialists has announced Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT, FAPhA, FADCES as the recipient of the 2025 Diabetes Care and Education Specialist of the Year Award, sponsored by Xeris Pharmaceuticals, Inc.

 

Media Contact:

Danielle McNary, [email protected]

August 10, 2024, CHICAGO, IL—The Association of Diabetes Care & Education Specialists (ADCES®) is pleased to announce that Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT, FAPhA, FADCES has been selected as the recipient of the 2025 Diabetes Care and Education Specialist of the Year Award. This award is sponsored by Xeris Pharmaceuticals, Inc.

Mobley-Bukstein is a Diabetes Care and Education Specialist and clinical pharmacist at a Federally Qualified Health Center (FQHC) in Des Moines, Iowa where she provides direct patient care as well as education and mentoring for the next generation of pharmacists. She currently teaches in the diabetes concentration at Drake University’s College of Pharmacy working with 100 students over the four-year graduate program. Mobley-Bukstein has strived throughout her career to find innovative solutions to improve patient care and has provided extensive community service working with underserved populations. Her most recent contributions to the field of research have focused on improving outcomes for older adults with diabetes and improving equitable use of continuous glucose monitors in underserved populations.

The Diabetes Care and Education Specialist of the Year Award honors a diabetes care and education specialist who has made a special contribution to the field through dedication, innovation and sensitivity in care. In addition to her many other contributions, Mobley-Bukstein’s ADCES service has included serving on the annual planning committee, the technology standing committee, professional practice committee, and advocacy committee, as well as working on with the ADCES Education Curriculum 3rd edition and articles for ADCES in Practice. 

“My deep passion for my profession as a pharmacist and my commitment to helping those with diabetes drive me every day,” said Mobley-Bukstein. “This award is recognition of the dedication and hard work that I put in; it is also a reminder that EVERY small thing you do adds up to something meaningful. I am grateful for the opportunity to serve ADCES and people with diabetes.”

 

About The Association of Diabetes Care & Education Specialists

ADCES is an interdisciplinary professional membership organization dedicated to improving prediabetes, diabetes and cardiometabolic care through innovative education, management and support. With more than 12,000 professional members including nurses, dietitians, pharmacists and others, ADCES has a vast network of practitioners working to optimize care and reduce complications. ADCES supports an integrated care model that lowers the cost of care, improves experiences and helps its members lead so better outcomes follow. Learn more at adces.org.

About Xeris

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies. Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings and maker of Gvoke HypoPen® (glucagon injection), is proud to be the first to develop liquid ready-to-use glucagon. Xeris Biopharma Holdings is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on X, LinkedIn, or Instagram.

 

Load more comments
avatar
Login to be able to comment